Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HE4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $111,765
Award facts
- Contract value 100% obligated
- $111,764.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $111,764.50 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of TAGRISSO 80 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 15, 2026, and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication used in the treatment of certain lung cancers, reflecting the Defense Logistics Agency's Medical Supply Chain mission to provide critical pharmaceutical products to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This master contract vehicle enables the company to serve as a comprehensive pharmaceutical prime vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill federal medical supply requirements through competitive procurement, with this award reflecting the company's role in supporting the military's extensive pharmaceutical and medical device distribution needs.
Quick answers
Who was awarded contract SPE2DR26F9HE4?
SPE2DR26F9HE4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F9HE4 worth?
The government has obligated $111,765 on SPE2DR26F9HE4.
Is contract SPE2DR26F9HE4 an order under another contract?
Yes. SPE2DR26F9HE4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HE4 competed?
The extent of competition for SPE2DR26F9HE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award